According to the latest research report by IMARC Group, the global hemodialysis market reached a value of US$ 80 Billion in 2020. Looking forward, the market expects to grow at a CAGR of 4.8% during 2021-2026.
Hemodialysis is a medical procedure that is administered on patients with kidney failure and other renal impairments. The process involves the utilization of a dialyzer or artificial kidney to remove urea and creatinine from the blood and restore electrolyte balance in the body. It also aids in managing the blood pressure levels and balancing the concentration of calcium, sodium and potassium in the circulatory system. Furthermore, hemodialysis prevents the accumulation of toxins and salts in the body that can influence the functioning of other organs.
Request for a sample copy of this report: https://www.imarcgroup.com/hemodialysis-market/requestsample
The global market is driven by the increasing prevalence of end-stage renal disease (ESRD) caused by high blood pressure, diabetes, excessive alcoholism and drug abuse, leading to gradual kidney failure. Furthermore, the development of compact hemodialysis machines, facilitating convenient home-based treatment, is also providing a boost to the market growth. Other factors, including increasing consumer awareness regarding the benefits of timely treatment of kidney-related ailments, enhanced research and development (R&D) and favorable government policies to improve healthcare infrastructure, are projected to drive the market further.
Explore full report with table of contents: https://bit.ly/3u15TiD
Key Market Segmentation:
Market Breakup by Segment:
Market Breakup by Modality:
Short Daily Hemodialysis
Market Breakup by End-User:
Independent Dialysis Centres
Breakup by Region:
Middle East and Africa
- Baxter International
- Asahi Kasei Corporation
- B. Barun Melsungen
- Cantel Medical Corporation
- Fresenius Medical Care
- Nipro Corporation
- Rockwell Medical
- Toray Medical Company Ltd.
- Nikkiso Co. Ltd.
- Surni Group
- Satellite Healthcare Inc.
- Renacon Pharma Ltd.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800